Article: Immune Response Corp. warns of bankruptcy filing. (Biotech).(Brief Article)

Carlsbad-based Immune Response Corp. warned in a regulatory filing it may cease operations and file for bankruptcy protection if it is unable to raise additional funds.

Immune Response said Nov. 20 it wants to raise up to $8 million through a private placement.

Cheshire Associates LLC, which is affiliated with Kevin Kimberlin, the firm's principal stockholder, may provide limited debt financing for up. to 60 days.

But Cheshire said the funding depends on Immune Response's ability to cut costs.

The biotech also said that Spencer Trask Ventures Inc., the placement agent for Immune Response's current private offering, may terminate the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!